In the setting of glioma, IL13Rα2, human erbb2 receptor tyrosine kinase 2 (HER2) and EGFRνIII are normally targeted proteins on the cancer cell’s surface (Figure 1, Table 3). This evidence concerns the gene IL13RA2 and central nervous system cancer.